22 Apr New Lachman Institute at the School of Pharmacy advances pharmaceutical development
Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move therapies from the lab into the clinic.
By Katie Gerhards, UW–Madison School of Pharmacy
The University of Wisconsin–Madison School of Pharmacy is launching a new center to leverage expertise across the School’s Pharmaceutical Sciences Division and greater UW–Madison campus community to advance the development of new drugs.
The new Lachman Institute for Pharmaceutical Development — made possible by renowned leader in dosage form design Leon Lachman (PhD ’56) — consolidates research into drug discovery, drug action, and drug delivery to accelerate the progress of new therapies from labs and into clinic settings.
“The Institute is based on the collective strengths of the different research centers across the School of Pharmacy, pulling them together under one umbrella to leverage our varied expertise, increase visibility, and combine forces into a streamlined and powerful drug development engine,” says Ed Elder, administrative director of the Lachman Institute.
The new Institute will increase visibility of drug development projects, create a cohesive alliance for collaborative grant submissions, and establish an umbrella structure to coordinate multidisciplinary research and instrumentation needs for conducting drug development that extends beyond the scope of the Institute’s individual affiliates. Read more …